Clinical Trial: A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness

U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06803654) titled 'A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness' on Jan. 27.

Brief Summary: To demonstrate the efficacy of BTOS-HA as non inferior to Lumify for treating ocular redness in a population of adult subjects.

Study Start Date: March 26

Study Type: INTERVENTIONAL

Condition: Ocular Redness

Intervention: DRUG: BTOS-HA

Brimonidine tartrate ophthalmic solution 0.025% with sodium hyaluronate (BTOS-HA) administered as 1 topical ocular drop instilled into each eye (OU), 4 times daily (QID), approximately 4 hours apa...